Progress, Potential, and Possibilities Podcast / Show · 2026-05-28 · 44 min
Send us Fan Mail What if the biggest problem in nuclear energy isn’t reactor technology…but paperwork, regulation, and institutional bottlenecks? Today we explore how AI could compress nuclear deployment timelines from decades to years. Kevin Kong is founder and CEO of Everstar ( ), a company building advanced AI reasoning systems designed to accelerate the deployment of nuclear power and modernize the infrastructure workflows surrounding the industry. Now when most people think about nuclear innovation, they think about reactors, fusion, uranium, or next-generation fuels. But Kevin and his team are focused on a very different problem - the massive institutional and cognitive bottlenecks that slow nuclear projects down. We’re talking about years of regulatory review, millions of pages of compliance documentation, fragmented engineering systems, workforce shortages, operational complexity, and the enormous burden of coordinating safety-critical infrastructure at scale.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
The Race to Build the Next Trillion-Dollar AI Chip CompanyTechSurge: Deep Tech Podcast · on Artificial intelligence90 / 100
Less about Models; More about ArchitecturePractical AI · on Artificial intelligence85 / 100
Code Review Is a Taste Problem | David Poll @GitHubHangar DX Podcast · on Artificial intelligence81 / 100
321 | How to Build an AI App Without Coding: From Idea to App Store with Replit & Claude by Bryce Rattner KeithleyLeveraging AI · on Artificial intelligence80 / 100
The Content Management System Landscape with Matt GarrepyRunAs Radio · on Artificial intelligence80 / 100
Rapid Response: OpenAI’s Critterz blowback - Director Nik Kleverov on year zero for HollywoodPioneers of AI · on Artificial intelligence76 / 100Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-ColtonThe End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart InstituteThe Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen